NeuroOne Medical Technologies Corporation (NASDAQ:NMTC) Q1 2025Management ViewCEO Dave Rosa highlighted the strong performance ...

Q4 2024 Earnings Call Transcript February 6, 2025 Zimmer Biomet Holdings, Inc. beats earnings expectations. Reported EPS is ...

Good morning, ladies and gentlemen, and welcome to the Zimmer Biomet Fourth Quarter 2024 Earnings Conference Call. [Operator Instructions] As a reminder, this conference is being recorded today, ...

Dave Rosa; President, Chief Executive Officer, Director; Neuroone Medical Technologies Corp. Ron McClurg; Chief Financial Officer; Neuroone Medical Technologies Corp ...

Total revenue of $6.3M Includes $3.3 Million of Product Revenue in Addition to a One-Time Upfront Payment of $3.0 Million in License Revenue from ...

NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) Q1 2025 Earnings Call Transcript February 12, 2025 NeuroOne Medical Technologies Corporation beats earnings expectations. Reported EPS is ...

Zimmer Biomet Holdings Inc (NYSE:ZBH), a leading player in the medical devices sector with a market capitalization of $22.12 billion, has been making strategic moves to strengthen its market position ...

Reports Q1 product revenue $3.3M vs. $1M last year. Reports Q1 license revenue $3M vs. $0 last year. “This quarter marks the next step forward ...

The ROSA Shoulder robotic application has received positive feedback, indicating strong potential for long-term growth in the robotics-assisted surgery segment. Additionally, Zimmer Biomet has ...

Medscape Medical News, November 07, 2019 Alert Class I Recall of Zimmer Biomet ROSA Robotic Surgery System The recall stemmed from a software issue with the ROSA 3.0 system that incorrectly ...

For instance, it is the only orthopedic company that offers a CT scanless robotic system in ROSA, Robotic Surgical Assistant. Additionally, Zimmer Biomet Holdings, Inc. (NYSE:ZBH) has built a ...